Clearside Biomedical, Inc. declined 2.17% in intraday trading. The news event related to Piper Sandler Companies acquiring G Squared Capital Partners, a boutique investment bank specializing in government services and defense technology, does not directly impact Clearside Biomedical, Inc. Therefore, the cause of the stock's decline is not explicitly clear from the given news events.
Comments
No comments yet